Homocysteine, intracellular signaling and thrombotic disorders

Current Medicinal Chemistry

Volumn 17, Issue 27, 2010, Pages 3109-3119

  Dionisio, N ^a   Jardin I ^a   Salido, G M ^a   Rosado, J A ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cell signaling; Homocysteine; Oxidative stress; Platelets

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHEMOKINE RECEPTOR CCR2; DNA METHYLTRANSFERASE; FERRITIN; FIBRINOGEN; FOLIC ACID; HEMOGLOBIN; HOMOCYSTEINE; IMMUNOGLOBULIN G;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC INFLAMMATION; DNA METHYLATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; FRACTURE; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; INTRACELLULAR SIGNALING; KIDNEY FAILURE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN INTERACTION; PROTEIN SYNTHESIS; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBOSIS; VASCULAR DISEASE;

ANIMALS; BLOOD PLATELETS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR DISEASES;

EID: 77955610177     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791959783     Document Type: Article

References (139)

1. Mansoor, M.A.; Bergmark, C.; Svardal, A.M.; Lonning, P.E.; Ue- land, P.M. Redox status and protein binding of plasma homocys- teine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol., 1995, 15(2), 232-240.
2. Jakubowski, H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J. Nutr., 2000, 130(2S Suppl), 377S-381S.
3. Jakubowski, H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol., 2008, 59 Suppl 9, 155-167.
4. Ji, C.; Kaplowitz, N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J. Gastroenterol., 2004, 10(12), 1699-1708.
5. van Guldener, C.; Stehouwer, C.D. Homocysteine-lowering treatment: an overview. Expert Opin. Pharmacother., 2001, 2(9), 1449-1460.
6. O'Callaghan, P.; Meleady, R.; Fitzgerald, T.; Graham, I. Smoking and plasma homocysteine. Eur. Heart J., 2002, 23(20), 1580-1586.
7. De Bree, A.; Verschuren, W.M.; Blom, H.J.; Kromhout, D. Alcohol consumption and plasma homocysteine: what's brewing? Int. J. Epidemiol., 2001, 30(3), 626-627.
8. van der Gaag, M.S.; Ubbink, J.B.; Sillanaukee, P.; Nikkari, S.; Hendriks, H.F. Effect of consumption of red wine, spirits, and beer on serum homocysteine. Lancet, 2000, 355(9214), 1522.
9. Ji, C.; Kaplowitz, N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology, 2003, 124(5), 1488-1499.
10. Medina, M.A. Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2. Circ. Res., 2008, 102(8), 869-870.
11. Groenendyk, J.; Michalak, M. Endoplasmic reticulum quality con trol and apoptosis. Acta Biochim. Pol., 2005, 52(2), 381-395.
12. Larner, S.F.; Hayes, R.L.; Wang, K.K. Unfolded protein response after neurotrauma. J. Neurotrauma, 2006, 23(6), 807-829.
13. Kaufman, R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev., 1999, 13(10), 1211-1233.
14. Rao, R.V.; Ellerby, H.M.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ., 2004, 11(4), 372-380.
15. Liu, C.Y.; Schroder, M.; Kaufman, R.J. Ligand-independent di-merization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem., 2000, 275(32), 24881-24885.
16. Kaufman, R.J. Regulation of mRNA translation by protein folding in the endoplasmic reticulum. Trends Biochem. Sci., 2004, 29(3), 152-158.
17. Lopez, J.J.; Redondo, P.C.; Salido, G.M.; Pariente, J.A.; Rosado, J.A. N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and -8 in human platelets. A role for endoplasmic reticulum stress. J. Thromb. Hae-most., 2009, 7(6), 992-999.
18. Dickhout, J.G.; Hossain, G.S.; Pozza, L.M.; Zhou, J.; Lhotak, S.; Austin, R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in athero-genesis. Arterioscler. Thromb. Vasc. Biol., 2005, 25(12), 2623-2629.
19. Uehara, T. Possible mechanism of neuronal death/neurodegen-erative disorders via endoplasmic reticulum stress induced by nitric oxide. Tanpakushitsu Kakusan Koso, 2007, 52(9), 988-995.
20. Gargalovic, P.S.; Gharavi, N.M.; Clark, M.J.; Pagnon, J.; Yang, W.P.; He, A.; Truong, A.; Baruch-Oren, T.; Berliner, J.A.; Kirch-gessner, T.G.; Lusis, A.J. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arte-rioscler. Thromb. Vasc. Biol., 2006, 26(11), 2490-2496.
21. Zhang, C.; Cai, Y.; Adachi, M.T.; Oshiro, S.; Aso, T.; Kaufman, R.J.; Kitajima, S. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J. Biol. Chem., 2001, 276(38), 35867-35874.
22. Agarwala, K.L.; Kokame, K.; Kato, H.; Miyata, T. Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem. Biophys. Res. Commun., 2000, 272(3), 641-647.
23. Kokame, K.; Agarwala, K.L.; Kato, H.; Miyata, T. Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress. J. Biol. Chem., 2000, 275(42), 32846-32853.
24. Cai, Y.; Zhang, C.; Nawa, T.; Aso, T.; Tanaka, M.; Oshiro, S.; Ichijo, H.; Kitajima, S. Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood, 2000, 96(6), 2140-2148.
25. Lentz, S.R. Mechanisms of homocysteine-induced atherothrombo-sis. J. Thromb. Haemost., 2005, 3(8), 1646-1654.
26. Zbidi, H.; Redondo, P.C.; Lopez, J.; Bartegi, A.; Salido, G.; Ro-sado, J.A. Homocysteine induces caspase activation by endoplas-mic reticulum stress in platelets from type 2 diabetics and healthy donors. Thromb. Haemost., 2010, 103(5), 10.1160/TH1109-1108-0552.
27. Leytin, V.; Allen, D.J.; Lyubimov, E.; Freedman, J. Higher throm-bin concentrations are required to induce platelet apoptosis than to induce platelet activation. B r. J. Haematol., 2007, 136(5), 762-764.
28. Leytin, V.; Allen, D.J.; Mykhaylov, S.; Lyubimov, E.; Freedman, J. Thrombin-triggered platelet apoptosis. J. Thromb. Haemost., 2006, 4(12), 2656-2663.
29. Lopez, J.J.; Salido, G.M.; Gomez-Arteta, E.; Rosado, J.A.; Pari-ente, J.A. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J. Thromb. Haemost., 2007, 5(6), 1283-1291.
30. Lopez, J.J.; Salido, G.M.; Pariente, J.A.; Rosado, J.A. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J. Thromb. Haemost., 2008, 6(10), 1780-1788.
31. Rosado, J.A.; Lopez, J.J.; Gomez-Arteta, E.; Redondo, P.C.; Sa-lido, G.M.; Pariente, J.A. Early caspase-3 activation independent of apoptosis is required for cellular function. J. Cell. Physiol., 2006, 209(1), 142-152.
32. Wang, J.; Weiss, I.; Svoboda, K.; Kwaan, H.C. Thrombogenic role of cells undergoing apoptosis. B r. J. Haematol., 2001, 115(2), 382-391.
33. Alexandru, N.; Jardin, I.; Popov, D.; Simionescu, M.; Garcia-Estan, J.; Salido, G.M.; Rosado, J.A. Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus. J. Cell Mol. Med., 2008, 12(5B), 2015-2026.
34. Jakubowski, H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. F A S E B J., 1999, 13(15), 2277-2283.
35. Jakubowski, H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem., 1997, 272(3), 1935-1942.
36. Perla-Kajan, J.; Stanger, O.; Luczak, M.; Ziolkowska, A.; Malen-dowicz, L.K.; Twardowski, T.; Lhotak, S.; Austin, R.C.; Jaku-bowski, H. Immunohistochemical detection of N-homocys-teinylated proteins in humans and mice. Biomed Pharmacother., 2008, 62(7), 473-479.
37. Beltowski, J.; Wojcicka, G.; Jakubowski, H. Modulation of par-aoxonase 1 (PON1) and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat. J. Endocrinol., 2010, 204, 191-198.
38. Jakubowski, H. New method for the determination of protein N-linked homocysteine. Anal. Biochem., 2008, 380(2), 257-261.
39. Glowacki, R.; Jakubowski, H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J. Biol. Chem., 2004, 279(12), 10864-10871.
40. Perla-Kajan, J.; Marczak, L.; Kajan, L.; Skowronek, P.; Twar-dowski, T.; Jakubowski, H. Modification by homocysteine thiolac-tone affects redox status of cytochrome c. Biochemistry, 2007, 46(21), 6225-6231.
41. Jakubowski, H.; Boers, G.H.; Strauss, K.A. Mutations in cys-tathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J., 2008, 22(12), 4071-4076.
42. Jakubowski, H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J. Biol. Chem., 2000, 275(6), 3957-3962.
43. Jakubowski, H.; Zhang, L.; Bardeguez, A.; Aviv, A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res., 2000, 87(1), 45-51.
44. Prinz-Langenohl, R.; Fohr, I.; Pietrzik, K. Beneficial role for folate in the prevention of colorectal and breast cancer. Eur. J. Nutr., 2001, 40(3), 98-105.
45. Ingrosso, D.; Perna, A.F. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim. Biophys. Acta, 2009, 1790(9), 892-899.
46. Bogdanovic, O.; Veenstra, G.J. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chro-mosoma, 2009, 118(5), 549-565.
47. Hoffman, D.R.; Marion, D.W.; Cornatzer, W.E.; Duerre, J.A. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. J. Biol. Chem., 1980, 255(22), 10822-10827.
48. Sharma, P.; Senthilkumar, R.D.; Brahmachari, V.; Sundaramoor-thy, E.; Mahajan, A.; Sharma, A.; Sengupta, S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lip-ids Health Dis., 2006, 5, 1.
49. Ridker, P.M.; Hennekens, C.H.; Roitman-Johnson, B.; Stampfer, M.J.; Allen, J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 1998, 351(9096), 88-92.
50. Mansoor, M.A.; Seljeflot, I.; Arnesen, H.; Knudsen, A.; Bates, C.J.; Mishra, G.; Larsen, T.W. Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hyper-triglyceridemia. Clin. Biochem., 2004, 37(5), 408-414.
51. Ravaglia, G.; Forti, P.; Maioli, F.; Martelli, M.; Servadei, L.; Bru-netti, N.; Porcellini, E.; Licastro, F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr., 2005, 82(3), 636-643.
52. Scarpa, S.; Fuso, A.; D'Anselmi, F.; Cavallaro, R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett., 2003, 541(1-3), 145-148.
53. Starkebaum, G.; Harlan, J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest., 1986, 77(4), 1370-1376.
54. McCully, K.S. Homocysteine and vascular disease. Nat. Med., 1996, 2(4), 386-389.
55. Heinecke, J.W.; Rosen, H.; Suzuki, L.A.; Chait, A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem., 1987, 262(21), 10098-10103.
56. Upchurch, G.R., Jr.; Welch, G.N.; Fabian, A.J.; Freedman, J.E.; Johnson, J.L.; Keaney, J.F., Jr.; Loscalzo, J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glu-tathione peroxidase. J. Biol. Chem., 1997, 272(27), 17012-17017.
57. Handy, D.E.; Zhang, Y.; Loscalzo, J. Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J. Biol. Chem., 2005, 280(16), 15518-15525.
58. Nishio, E.; Watanabe, Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. B r. J. Pharmacol., 1997, 122(2), 269-274.
59. Nonaka, H.; Tsujino, T.; Watari, Y.; Emoto, N.; Yokoyama, M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation, 2001, 104(10), 1165-1170.
60. Tawakol, A.; Omland, T.; Gerhard, M.; Wu, J.T.; Creager, M.A. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation, 1997, 95(5), 1119-1121.
61. Rubbo, H.; Darley-Usmar, V.; Freeman, B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol., 1996, 9(5), 809-820.
62. De Caterina, R.; Libby, P.; Peng, H.B.; Thannickal, V.J.; Rajavash-isth, T.B.; Gimbrone, M.A., Jr.; Shin, W.S.; Liao, J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 1995, 96(1), 60-68.
63. Eberhardt, R.T.; Forgione, M.A.; Cap, A.; Leopold, J.A.; Rudd, M.A.; Trolliet, M.; Heydrick, S.; Stark, R.; Klings, E.S.; Moldovan, N.I.; Yaghoubi, M.; Goldschmidt-Clermont, P.J.; Farber, H.W.; Cohen, R.; Loscalzo, J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest., 2000, 106(4), 483-491.
64. Stamler, J.S.; Simon, D.I.; Osborne, J.A.; Mullins, M.E.; Jaraki, O.; Michel, T.; Singel, D.J.; Loscalzo, J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A., 1992, 89(1), 444-448.
65. Stamler, J.S.; Singel, D.J.; Loscalzo, J. Biochemistry of nitric oxide and its redox-activated forms. Science, 1992, 258(5090), 1898-1902.
66. Gryglewski, R.J.; Palmer, R.M.; Moncada, S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986, 320(6061), 454-456.
67. Kuzkaya, N.; Weissmann, N.; Harrison, D.G.; Dikalov, S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem., 2003, 278(25), 22546-22554.
68. Topal, G.; Brunet, A.; Millanvoye, E.; Boucher, J.L.; Rendu, F.; Devynck, M.A.; David-Dufilho, M. Homocysteine induces oxida-tive stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med., 2004, 36(12), 1532-1541.
69. Boger, R.H.; Bode-Boger, S.M.; Szuba, A.; Tsao, P.S.; Chan, J.R.; Tangphao, O.; Blaschke, T.F.; Cooke, J.P. Asymmetric dimethy-larginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation, 1998, 98(18), 1842-1847.
70. Ghosh, S.K.; Paik, W.K.; Kim, S. Purification and molecular identification of two protein methylases I from calf brain. Myelin basic protein- and histone-specific enzyme. J. Biol. Chem., 1988, 263(35), 19024-19033.
71. Lentz, S.R.; Rodionov, R.N.; Dayal, S. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atheroscle r. Suppl., 2003, 4(4), 61-65.
72. Zhu, W.G.; Li, S.; Lin, L.Q.; Yan, H.; Fu, T.; Zhu, J.H. Vascular oxidative stress increases dendritic cell adhesion and transmigration induced by homocysteine. Cell. Immunol., 2009, 254(2), 110-116.
73. Rosado, J.A. In Textbook of hemostasis and blood coagulation. Rosado, J.A., Ed.; Research Signpost: Kerala, 2009, pp 1-20.
74. Roth, J.; Goebeler, M.; Ludwig, S.; Wagner, L.; Kilian, K.; Sorg, C.; Harms, E.; Schulze-Osthoff, K.; Koch, H. Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-kappa b activity. Biochim. Biophys. Acta, 2001, 1540(2), 154-165.
75. Wang, G.; O, K. Homocysteine stimulates the expression of mono-cyte chemoattractant protein-1 receptor (CCR2) in human mono-cytes: possible involvement of oxygen free radicals. Biochem. J., 2001, 357(Pt 1), 233-240.
76. Maeda, M.; Yamamoto, I.; Fujio, Y.; Azuma, J. Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim. Biophys. Acta, 2003, 1623(1), 41-46.
77. Karabag, T.; Kaya, A.; Temizhan, A.; Koc, F.; Yavuz, S.; Cam, S. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease. Acta Diabetol., 2007, 44(2), 69-75.
78. van Guldener, C.; Stehouwer, C.D. Diabetes mellitus and hyper-homocysteinemia. Semin. Vasc. Med., 2002, 2(1), 87-95.
79. Dalton, M.L.; Gadson, P.F., Jr.; Wrenn, R.W.; Rosenquist, T.H. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J., 1997, 11(8), 703-711.
80. Majors, A.; Ehrhart, L.A.; Pezacka, E.H. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 1997, 17(10), 2074-2081.
81. Chaussalet, M.; Lamy, E.; Foucault-Bertaud, A.; Genovesio, C.; Sabatier, F.; Dignat-George, F.; Charpiot, P. Homocysteine modulates the proteolytic potential of human vascular endothelial cells. Biochem. Biophys. Res. Commun., 2004, 316(1), 170-176.
82. Ke, X.D.; Foucault-Bertaud, A.; Genovesio, C.; Dignat-George, F.; Lamy, E.; Charpiot, P. Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol. Cell. Biochem., 2010, 335, 203-210.
83. Shattil, S.J.; Montgomery, J.A.; Chiang, P.K. The effect of phar-macologic inhibition of phospholipid methylation on human platelet function. Blood, 1982, 59(5), 906-912.
84. Berridge, M.J.; Lipp, P.; Bootman, M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol., 2000, 1(1), 11-21.
85. Rosado, J.A.; Redondo, P.C.; Salido, G.M.; Pariente, J.A. Calcium signalling and reactive oxygen species in non-excitable cells. Mini Rev. Med. Chem., 2006, 6(4), 409-415.
86. 2+ release from two different intracellular stores in human platelets. Biochem. J., 2007, 401(1), 167-174.
87. Jardin, I.; Lopez, J.J.; Pariente, J.A.; Salido, G.M.; Rosado, J.A. Intracellular calcium release from human platelets: different messengers for multiple stores. Trends Cardiovasc. Med., 2008, 18(2), 57-61.
88. +-ATPases in human platelets. Biochem. J.,2005, 390(Pt 1), 243-252.
89. 2+ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets. Cell. Signal.2006, 18(3), 373-381.
90. Putney, J.W., Jr. A model for receptor-regulated calcium entry. Cell Calcium, 1986, 7(1), 1-12.
91. 2+ channels. Cell. Signal., 2009, 21(4), 457-461.
92. 2+ entry. Biochim. Biophys. Acta, 2009, 1793(2), 223-230.
93. 2+ entry pathways. Biochem. J., 2009, 420(2), 267-276.
94. 2+ channels. J. Biol. Chem., 2008, 283(37), 25296-25304.
95. 2+ stores. J. Biol. Chem., 2006, 281(38), 28254-28264.
96. Jardin, I.; Salido, G.M.; Rosado, J.A. Role of lipid rafts in the interaction between hTRPC1, Orai1 and STIM1. Channels (Austin), 2008, 2(6), 401-403.
97. 2+ entry in human platelets. Cell. Signal., 2008, 20(4), 737-747.
98. Rosado, J.A.; Sage, S.O. The ERK cascade, a new pathway involved in the activation of store-mediated calcium entry in human platelets. Trends Cardiovasc. Med., 2002, 12(5), 229-234.
99. 2+ entry in human platelets. Cell. Signal., 2005, 17(8), 1011-1021.
100. Redondo, P.C.; Harper, M.T.; Rosado, J.A.; Sage, S.O. A role for cofilin in the activation of store-operated calcium entry by de novo conformational coupling in human platelets. Blood, 2006, 107(3), 973-979.
101. Galan, C.; Zbidi, H.; Bartegi, A.; Salido, G.M.; Rosado, J.A. STIM1, Orai1 and hTRPC1 are important for thrombin- and ADP-induced aggregation in human platelets. Arch. Biochem. Biophys., 2009, 490(2), 137-144.
102. Redondo, P.C.; Salido, G.M.; Pariente, J.A.; Rosado, J.A. Dual effect of hydrogen peroxide on store-mediated calcium entry in human platelets. Biochem. Pharmacol., 2004, 67(6), 1065-1076.
103. Redondo, P.C. In Textbook of hemostasis and blood coagulation. Rosado, J.A., Ed.; Research Signpost: Kerala, 2009, pp 47-60.
104. Fryer, R.H.; Wilson, B.D.; Gubler, D.B.; Fitzgerald, L.A.; Rodgers, G.M. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb., 1993, 13(9), 1327-1333.
105. Undas, A.; Williams, E.B.; Butenas, S.; Orfeo, T.; Mann, K.G. Homocysteine inhibits inactivation of factor Va by activated protein C. J. Biol. Chem., 2001, 276(6), 4389-4397.
106. Hajjar, K.A. Homocysteine-induced modulation of tissue plasmi-nogen activator binding to its endothelial cell membrane receptor. J. Clin. Invest., 1993, 91(6), 2873-2879.
107. Nishinaga, M.; Ozawa, T.; Shimada, K. Homocysteine, a throm-bogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J. Clin. Invest., 1993, 92(3), 1381-1386.
108. Jakubowski, H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J. Biol. Chem., 2002, 277(34), 30425-30428.
109. Sauls, D.L.; Lockhart, E.; Warren, M.E.; Lenkowski, A.; Wilhelm, S.E.; Hoffman, M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry, 2006, 45(8), 2480-2487.
110. Bushnell, C.D.; Goldstein, L.B. Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients. J. Stroke Cere-brovasc. Dis., 2005, 14(3), 101-106.
111. Malinowska, A.; Chmurzynska, A. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease. Nutr. Res., 2009, 29(10), 685-695.
112. Joseph, J.; Joseph, L.; Devi, S.; Kennedy, R.H. Effect of anti-oxidant treatment on hyperhomocysteinemia-induced myocardial fibrosis and diastolic dysfunction. J. Heart Lung Transplant., 2008, 27(11), 1237-1241.
113. Zhang, D.; Jiang, X.; Fang, P.; Yan, Y.; Song, J.; Gupta, S.; Schafer, A.I.; Durante, W.; Kruger, W.D.; Yang, X.; Wang, H. Hy-perhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation, 2009, 120(19), 1893-1902.
114. Mishra, P.K.; Tyagi, N.; Kundu, S.; Tyagi, S.C. MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell. Bio-chem. Biophys., 2009, 55(3), 153-162.
115. Nagy, V.; Takacs, L.; Steiber, Z.; Pfliegler, G.; Berta, A. Thrombo-philic screening in retinal artery occlusion patients. Clin. Ophthal-mol., 2008, 2(3), 557-561.
116. Sen, U.; Basu, P.; Abe, O.A.; Givvimani, S.; Tyagi, N.; Metreveli, N.; Shah, K.S.; Passmore, J.C.; Tyagi, S.C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol. Renal Physiol., 2009, 297(2), F410-419.
117. Guerzoni, A.R.; Biselli, P.M.; Godoy, M.F.; Souza, D.R.; Haddad, R.; Eberlin, M.N.; Pavarino-Bertelli, E.C.; Goloni-Bertollo, E.M. Homocysteine and MTHFR and VEGF gene polymorphisms: impact on coronary artery disease. Arq. Bras. Cardiol., 2009, 92(4), 263-268.
118. Bialecka, M.; Robowski, P.; Honczarenko, K.; Roszmann, A.; Slawek, J. Genetic and environmental factors for hyperhomocyste-inaemia and its clinical implications in Parkinson's disease. Neurol. Neurochir. Pol., 2009, 43(3), 272-285.
119. Palleschi, S.; De Angelis, S.; Rossi, B.; Diana, L.; Papa, V.; Sever-ini, G.; Splendiani, G. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease. Nephron. Clin. Pract., 2008, 108(2), c106-112.
120. van Guldener, C.; Stam, F.; Stehouwer, C.D. Hyperhomocystein-aemia in chronic kidney disease: focus on transmethylation. Clin. Chem. Lab. Med., 2005, 43(10), 1026-1031.
121. de Gomez Dumm, N.T.; Giammona, A.M.; Touceda, L.A. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid. Int. J. Vitam. Nutr. Res., 2003, 73(3), 215-220.
122. Yilmaz, N.; Pektas, M.; Tonguc, E.; Kilic, S.; Gulerman, C.; Gun-gor, T.; Mollamahmutoglu, L. The correlation of plasma homocys-teine with insulin resistance in polycystic ovary syndrome. J. Ob-stet. Gynaecol. Res., 2008, 34(3), 384-391.
123. Kazerooni, T.; Asadi, N.; Dehbashi, S.; Zolghadri, J. Effect of folic acid in women with and without insulin resistance who have hy-perhomocysteinemic polycystic ovary syndrome. Int. J. Gynaecol. Obstet., 2008, 101(2), 156-160.
124. Maron, B.A.; Loscalzo, J. The treatment of hyperhomocysteinemia. Annu. Rev. Med., 2009, 60, 39-54.
125. Papandreou, D.; Malindretos, P.; Arvanitidou, M.; Makedou, A.; Rousso, I. Homocysteine lowering with folic acid supplements in children: effects on blood pressure. Int. J. Food Sci. Nutr., 2010, 61(1), 11-17.
126. Khedr, E.M.; Hamed, S.A.; El-Shereef, H.K.; Shawky, O.A.; Mo-hamed, K.A.; Awad, E.M.; Ahmed, M.A.; Shehata, G.A.; El-tahtawy, M.A. Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors. Neuropsychiatr. Dis. Treat., 2009, 5, 103-116.
127. Flicker, L. Life style interventions to reduce the risk of dementia. Maturitas, 2009, 63(4), 319-322.
128. Davis, G.; Baboolal, N.; Nayak, S.; McRae, A. Sialic acid, homo-cysteine and CRP: potential markers for dementia. Neurosci. Lett., 2009, 465(3), 282-284.
129. +-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia. Int. J. Dev. Neurosci., 2006, 24(1), 3-8.
130. Murthy, J.M. Hyperhomocysteinemia, ischemic stroke, and B-vitamin treatment: the jury is still out. Neurol. India, 2005, 53(3), 271-272.
131. Chen, X.; Jhee, K.H.; Kruger, W.D. Production of the neuromodu-lator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. J. Biol. Chem., 2004, 279(50), 52082-52086.
132. Vitvitsky, V.; Thomas, M.; Ghorpade, A.; Gendelman, H.E.; Ban-erjee, R. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J. Biol. Chem., 2006, 281(47), 35785-35793.
133. Jhee, K.H.; Kruger, W.D. The role of cystathionine beta-synthase in homocysteine metabolism. Antioxid. Redox Signal, 2005, 7(5-6), 813-822.
134. LeBoff, M.S.; Hawkes, W.G.; Glowacki, J.; Yu-Yahiro, J.; Hur-witz, S.; Magaziner, J. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos. Int., 2008, 19(9), 1283-1290.
135. Leboff, M.S.; Narweker, R.; LaCroix, A.; Wu, L.; Jackson, R.; Lee, J.; Bauer, D.C.; Cauley, J.; Kooperberg, C.; Lewis, C.; Thomas, A.M.; Cummings, S. Homocysteine levels and risk of hip fracture in postmenopausal women. J. Clin. Endocrinol. Metab., 2009, 94(4), 1207-1213.
136. Yilmaz, N.; Eren, E. Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin. Exp. Res., 2009, 21(4-5), 353-357.
137. Holstein, J.H.; Herrmann, M.; Splett, C.; Herrmann, W.; Garcia, P.; Histing, T.; Graeber, S.; Ong, M.F.; Kurz, K.; Siebel, T.; Menger, M.D.; Pohlemann, T. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am. J. Clin. Nutr., 2009, 90(5), 1440-1445.
138. Sato, Y.; Honda, Y.; Iwamoto, J.; Kanoko, T.; Satoh, K. Homocys-teine as a predictive factor for hip fracture in stroke patients. Bone, 2005, 36(4), 721-726.
139. Sato, Y. Immobilization and hip fracture. Clin. Calcium, 2006, 16(12), 1991-1998.